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Summary: Light scattering due to the formation of insoluble complexes between the long-chain quaternary
ammonium sah N-cetylpyridinium chloride and glycosaminoglycans was utilized for a relative simple, sensi-
tive and precise determination of total and specific types of glycosaminoglycans by laser nephelometry. The
addition of the ammonium salt to Solutions of various glycosaminoglycans in 0.03 mol/1 NaCl produces a
time-dependent increase in light scattering, which reaches a maximum between 14 and 18h of complex
formation, irrespective of the type of glycosaminoglycan studied. Only keratan sulphate does not generate
light scattering, and is therefore not detectable by the procedure. The scattering of laser light by certain types
of sulphated glycosaminoglycans (e.g. heparan sulphate, heparin) depends more on the degree of sulphation
(charge density) than on chain length within a certain ränge. Optimum light scattering was found at 28 mmol/l
N-cetylpyridinium chloride and at a ionic strength around 0.03 mol/1 NaCl.
The detection limits and linear ranges of the individual glycosaminoglycans were evaluated. For the determi-
nation of chondroitin sulphate, laser nephelometry is at least 8 times more sensitive and much more simple
than the modified carbazole method (glucuronic acid). The intra-assay and inter-assay coefficients of Varia-
tion are about 4% and 7%, respectively. Laser nephelometry is much more sensitive than turbidimetry.
Complex synthetic mixtures of glycosaminoglycans and biological fluids were accurately differentiated by
successive chemical and enzymatic degradation of the respective glycosaminoglycans followed by the mea-
surement of the resulting reduction of laser light scattering. In synovial fluids from non-inflammatory joint
diseases, light scattering (units/ml) was about 4.5 times higher than in synovial fluids from inflammatory
articular lesions. In both pathologic conditions nearly all of the light scattering can be attributed to hyaluronic
acid.
Lasernephelometrische Bestimmung der Glykosaminoglykane — Methode und klinische Anwendung
Zusammenfassung: Lichtstreuüng durch Bildung unlöslicher Komplexe zwischen dem langkettigen quater-
nären Ammoniumsalz N-Cetylpyridiniumchlorid und Glykosaminoglykanen wurde für eine relativ einfache,
empfindliche und präzise Bestimmung der gesamten und speziellen Glykosaminoglykane mittels Laser-
nephelometrie nutzbar gemacht. Die Zugabe des Ammoniumsalzes zu Lösungen verschiedener
Glykosaminoglykane in 0,03 mol/1 NaCl erzeugt einen zeitabhängigen Anstieg des Streulichtes, welches ein
Maximum 14 bis 18 Stunden nach Komplexbildung erreicht, unabhängig von dem jeweiligen Typ der Gly-
kosaminoglykane. Nur Keratansulfat erzeugt keine Streulichtzunahme und ist somit nicht nachweisbar. Für
die Eigenschaft der Laserlichtstreuung bestimmter sulfatierter Glykosaminoglykantypen (z. B. Heparansulfat,
Heparin) ist der Grad der Sulfatierung (Ladungsdichte) kritischer als Variationen ihrer Kettenlänge innerhalb
eines gewissen Bereiches.
Optimale Lichtstreuung wurde gefunden bei 28 mmol/l N-Cetylpyridiniumchlorid und bei einer lonenstärke
um 0,03 mol/1 NaCl. Die Nachweisgrenzen und linearen Bereiche der individuellen Glykosaminoglykane
wurden bestimmt. Im Vergleich zur Bestimmung des Chondroitinsulfates durch die modifizierte Carbazol-
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reaktion (Glucuronsäure) erweist sich die Lasernephelometrie als mindestens 8 mal empfindlicher und
wesentlich einfacher. Die Variationskoeffizienten der Bestimmungen in der Serie und von Tag zu Tag betra-
gen jeweils 4% und 7%. Im Vergleich zur Turbidimetrie ist die Lasernephelometrie wesentlich empfindlicher.
Komplizierte synthetische Gemische von Glykosaminoglykanen und biologische Flüssigkeiten können zuver-
lässig durch aufeinanderfolgende chemische und enzymatische Degradation der Glykosaminoglykane, gefolgt
von der Messung der resultierenden Abnahme der Laserlichtstreuung, differenziert werden.'Durch Anwen-
dung dieses analytischen Prinzips wurden in Synovialflüssigkeiteri nicht-entzündlicher Gelenkefgüsse etwa
4,5 mal soviel Streulichteinheiten wie in jenen entzündlicher Gelenkerkrarikungen festgestellt. Unter beiden
pathologischen Bedingungen ist nahezu das gesamte Streulicht auf Hyaluronsäure zurückzuführen.
Introduction
Glycosaminoglycans are complex linear (un-
branched) heteropolysaccharides which are coval-
ently linked to a core protein forming a high molecu-
lar weight proteoglycan (1—4). With the exception
of hyaluronic acid, which is not covalently bound to a
protein moiety, the components of the serially re-
peating disaccha^de unit are substituted with sul-
phate residues, thus giving the total molecule a high-
ly anionic Charge. Due to variations in the composi-
tion of the disaccharide unit (usually N-acetylgluco-
samine, N-acetylgalactosamine and glucuronic acid,
iduronic acid), in the Charge density, in the distribu-
tion of sulphate residues between glucuronic acid
and hexosamine, and in the chain length (molecular
weight), glycosaminoglycans comprise a greatly he-
terogeneous class of carbohydrates with a high de-
gree of molecular polydispersity (5).
Glycosaminoglycans are main constituents of the in-
tercellular matrix in tissues such äs cartilage, skin
and cornea (4) but are also present in parenchymat-
ous organs like liver (6), brain (7, 8), and kidney (9,
10). In the latter type of tissues glycosaminoglycans
are also distributed intracellularly (10, 12) and peri-
cellularly (9, 13, 14). This subcellular localization
suggests that glycosaminoglycans may have some äs
yet unknown regulatory role, in addition to their me-
chanical functions in the intercellular compartment.
The presence of glycosaminoglycans not oftly in
tissues but also in several body fluids, e.g. serum
(15-17), urine (18), amniotic fluid (19), and synov-
ial fluid (20) has been well documented. Although
characteristic changes of the total amount and, more
seldom, of the pattern of glycosaminoglycans in se-
rum and urine have been described in acquired (21-
25) and hereditary (26-29) diseases, our present
knowledge of the possible pathobiochemical or diag-
nostic significance of these alterations is limited. This
failure is partly due to the difficulties inherent in the
methods of determination.
The structural diversity of glycosaminoglycans and
some of their structural similarities to glycoproteins
have seriously complicated the development of ana-
lytic procedures with both sensitivity and specificity
for the individual types of glycosaminoglycans.
Whereas ion^exchange chromätogiaphic Separation
and differential extraction or fractionatiön of glycos-
aminoglycans are valüable fesearch tools (30) these
methods are too laborious for applicaticm in the röu-
tine laboratory. Electrophoresis of glycosaminogly-
cans, using a öne-dimensional (31^33), öf tw<>di-
mensional System (34, 35) has been suggested äs a
method suitable for routine analysis, but incomplete
Separation of the bands partly due to the heteroge-
neity of individual glycosaminoglycans and species
Variation between tissue or fluid and reference gly-
cosaminoglycans are frequent limiting factors in the
identification of glycosaminoglycans. For routine
purposes the fofmätion of insoluble complexes be-
tween anionic polysaccharides and a variety of catio^
nie substances has been utilized in a great number of
modifications (30, 36). The glyeosaminogiycan-pre-
cipitating ability of the cationic dye Alcian Blüe
8GX (37) has been exploited for quantitative mea-
surement of glycosaminoglycans in urine (38, 39)
and serum (40), respectively, but the specificity of
the method in complex biological fluids is limited
(4l).
The introduction of long-chain quaternary ammoni-
um salts such äs N-cetylpyridinium Chloride and ce-
tyltrimethylammonium brpmide (42, 43) äs precipi-
tating agents of glycosaminoglycans has greatly facil-
itated the development of relatively simple and relia-
ble procedures for their quantitation and Isolation.
Both quaternary ammonium salts have been applied
for the measureiiient of glycosaminoglycans in serum
(45, 46) and urine (22, 23, 24, 44), respectively. A
further improvement of practicability was achieved
by utilizing the formation of relatively iiisöluble
complexes between cetyltrimethylammonium brom-
ide and N-cetylpyridinium Chloride, respectively,
and glycosaminoglycans in a turbidimetric assay of
the latter in body fluids (47-49). Although this ana-
lytic principle offers a convenient method for the de-
termination of glycosaminoglycari^, the relatively
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low sensitivity proves to be disadvantageous. In the
present study, we have used this method of complex
formation, and we have combined the advantage of a
homogeneous assay System with the sensitivity pro-
vided by laser nephelometry for the rneasurement of
glycosaminoglycans in fluids.
Individual glycosaminoglycans were identified by
their selective chemical and enzymatic destruction.
A preliminary description of the method has been
given elsewhere (50). After completion of the pres-
ent studies, Warren and Manley (51) reported on a
laser nephelometric measurement of glycosamino-
glycans in human serum.
Materials and Methods
Chondroitin AC lyase (EC 4.2.2.5, lot E 0602) and chondroitin
ABC lyase (EC 4.2.2.4, lot E 8804) were purchased from Seika-
gaku Kogyo Comp., Tokyo, Japan; a crude fraction of Streptomy-
ces hyaluronate lyase (EC 4.2.2.1, Op 166 I/II, 500 U/mg pro-
tein) was kindly provided from Behring Werke AG, Marburg,
FRG; -cetylpyridinium Chloride (monohydrate) was from E.
Merck AG, Darmstadt, FRG; Arteparon (glycosaminoglycan pol-
ysulphate, a chemically oversulphated chondroitin sulphate, lot.
79204 79) was obtained from Luitpold Werke, Munich, FRG.
High molecular weight calf thyrnus DNA (lot. 737 5409) and
RNA (a mixture of 16S and 23S ribosomal RNA from £. coli
MRE 600, lot. 135 7403) were purchased from Boehringer
GmbH, Mannheim, FRG. The natural glycosaminoglycans were
purified from the following sources:
chondroitin sulphate from bovine tracheal cartilage (52),
dermatan sulphate from pig skin (53),
keratan suiphate from pig cornea (54),
heparan suphate (Upjohn Comp. Kaiarnazoo, USA) from pig mu-
cosa was repurified and separated by Dowex chromatography into
low and highly sulphated subfractions with sulfale/glucosamine
molar ratios of 0.31 and 2.40, respectively;
heparin (Upjohn Comp.) frorri pig rhucosa, with a sulfate/glu-
cosamine molar ratio of 1.87, was separated into a low (< 4000)
and a high molecular weight fraction; hyaluronic acid was isolated
from human synovial fluid.
Preparation of samples
Synovial fluids were obtained by puncture from diseased joints.
The condition of the diseased joints was classified äs inflammatory
or n on-inflammatory according to cytological, clinicalrchemical
and physico-chemical criteria (55, 56). To remove the cells the
synovial fluids were centrifuged for 15 min, 1500g, 25 °C and the
cell-free supernatant kept at ^20 °C until analysis was performed.
The material was diluted l : 40 with 0.03 mol/1 NaCI and filtered
through Millex filters before Nrcetylpyridinium Chloride was
added äs described below.
Determination of purified glycosaminoglycans by 'laser lighf scat-
tering
Unless otherwise stated the principle procedure for the measure-
ment of glycosaminoglycans was äs follows. Highly concentrated
stock Solutions (l g/l) of the various glycosaminoglycans in
0.03 mol/1 NaCI were prepared and diluted geometricälly with
0.03 mol/I NaCI to obtain the final concentrations. The various
dilutions were filtered through Millex disposable filters (MiHipore
GmbH, Neu-Isenburg, FRG) and the 'light scattering, normally
between 0.06 and 0.08 V, was measurcd. N-cetylpyridinium Chlo-
ride was used äs a 0.28 mol/1 solution in 0.03 mol/1 NaCI and fil-
tered äs above. Light scattering of this solution was lower than
0.03 V.
200 of the Solutions of glycosaminoglycans were mixed in LN-
cuvettes (Behring Werke AG, Marburg, FRG) with 0.1 volume
(20 ) ofthe N-cetylpyridinium Chloride solution and incubated
for various' times, routinely 24 h, at room temperature. Before
measurement the mixture was thoroughly whirled. The intensity
of light scattering (voltage. V) was determined in a helium-neon
laser nephelometer (wave length 632.8 nm, Behring Werke AG,
Marburg) equipped with an automatic cuvette transport system
and a Hewlett-Packard 9815 A microcomputer. For the final cal-
culation light scattering of blank incubations was subtracted from
those of the complete N-cetylpyridinium chloride-glycosamino-
glycan mixture.
Determination ofspecific glycosaminoglycans in synfheiic mixtures
of purified glycosaminoglycans and in body fluids by laser light
scattering
Mixtures of different glycosaminoglycans, of which the concentra-
tion and the laser light scattering of the individual compounds
were known, were prepared in 0,03 mol/1 NaCI and subjected to
chemical and enzymatic treatment äs described previously (57).
For estimation of N-suIphated glycosaminoglycans (heparan sul-
phate, heparin) the assay, total volume 1.20 ml, contained 1.0 ml
glycosaminoglycan solution, O . l m l of 1.5 mol/1 NaNÜ2 and
0.1 ml l : 5 diluted glacial acetic acid. The control incubation had
a'similar composition but NaNOa was omitted. Light scattering by
the blank incubations (without added cetylpyridinium Chloride) of
both assay and control was similar and lower than 0.1 V: it was
therefore neglected. The mixtures were incubated for 80 min at
37 °C, heated (100°C, l min), cooled and centrifuged (4min,
2000g). 0.12ml N-cetylpyridinium Chloride solution was added
to the filtered supernatant, mixed and used for light scattering
measurement äs described above.
The fraction of heparan sulphate and heparin in the mixture was
calculated from the difference in the light scattering intensity be-
tween assay and control incubation.
The proportion of chondroitin sulphate in the mixtures was deter-
mined by degradation with chondroitin AC lyase (EC 4.2.2.5)
(58). The assay, total volume 0.60 ml, contained 0.3 ml glycosa-
minoglycan solution, 0.1 ml "enriched" Tris-HCl buffer. pH 8.0
and 0.2 ml (l unit) chondroitin AC lyase. The proportion of chon-
droitin sulphate + dermatan sulphate was determined similarly,
but the assay contained 0.2 ml (l unit) of chondroitin ABC lyase
(EC 4.2.2.4) instead of AC lyase. The control incubations were
composed sirnilarly but enzymes were omitted. Blank incubations
(without N-cetylpyridinium Chloride) of both assay and control
gave similar, low light scattering (<0. l V), and were therefore
neglected. After incubation for 3h at 37 °C the mixtures were
heated at 100 °C for l min, cooled, centrifuged for 4 min at 2000 g
and the supernatant filtered through Millex filters. After addition
of 0.06 ml N-cetylpyridinium Chloride solution light scattering was
measured äs above.
The fraction of chondroitin sulphate + dermatan sulphate was
calculated from the difference in the light scattering between the
ABC lyase assay and the control incubation. The fraction of chon-
droitin sulphate was calculated from the respective difference be-
tween the AC lyase assay and control incubation, and the fraction
of dermatan sulphate was calculated from the difference in the
light scattering between the AC-lyasc and ABC-lyase assay of
which the control incubations are identical. It should be noted that
due to the partial degradation of hyaluronate by chondroitin
lyases the procedure is only valid if hyaluronate is either absent
from the mixture or has been rcmoved by digestion with hyaluro-
nate lyase.
The portion of hyaluronic acid in the mixture of glycosaminogly-
cans was measured by selective destruction ofthe glycosaminogly-
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can with hyaluronatc lyasc (EC 4.2.2.1) (57, 59). The assay, total
volume 1.5ml, contained 0.5ml glycosaminoglycan solution,
0.5 ml 0.1 mol/1 sodium acctate. pH 5.0 and 0.5 ml hyaluronatc
lyase (250 units).
The control incubation did not contain hyaluronate lyase but oth-
erwise had a similar composition. The respectivc blank incubation
was omitted. The mixtures were incubated for 20 h at 37 °C and
processed äs dcscribcd for chondroitin sulphate. After addition of
0.15 ml N-cetylpyridinium Chloride solution the intensity of scat-
tered light was recorded äs mentioned above. The fraction ofhya-
luronic acid was calculated from the difference in thc light scatter-
ing between assay and control incubation.
If the concentrations (mg/1) rather than the relative fractions of
specific glycosaminoglycans are required, the intensity of light
scattering of the individual glycosaminoglycans determined äs
above is refered to a calibration curve of known concentrations of
the respective, highly purified type of glycosaminoglycan. The
specific types used äs references are described in the legends to
the tables and figures. Special care was taken to ensure that light
scattering was in the linear ränge of glycosaminoglycan concentra-
tion by measuring various dilutions in 0.03 mol/1 NaCl of the gly-
cosaminoglycan-containing samples, e.g. urine, synovial fluid and
arteficial mixtures.
Determination of glycosaminoglycans by turbidimetry
The solution of glycosaminoglycans and the incubation with N-ce-
tylpyridinium Chloride were exactly äs described for nephelome-
try. The turbidity of the glycosaminoglycan-N-cetylpyridinium
Chloride mixture was read at 340 nm using a centrifugal fast anä-
lyzer (GEMSAEC Electro Nucleonics, USA). Only the absor-
bance of the first reading was recorded because subsequent read-
ings (reading interval 60 s) produced false low absorbance values
due to a Sedimentation of the glycosaminoglycan-N-cetylpyridini-
um Chloride complex. All measurements were performed at least
in triplicate.
Other analylical procedures
Uronic acid was determined according to the Bitter & Muir modi-
fication (60) of the carbazole reaction introduced by Dische (61).
The analysis was mechanized by adaptation to a Technicon Auto-
analyzer II System.
Results
Characteriiation of the glycosammoglycan-N-cetyl-
pyridinium Chloride complex formation by laser light
scattering measurements
The addition of N-cetylpyridinium Chloride to var-
ious Solutions of specific glycosaminoglycans in
0.03 mol/1 NaCl produces a time dependent iiicrease
in laser light scattering (fig. 1). The rate of increase is
influenced by the concentration of glycosamino-
glycan because being higher for more concentrated
Solutions (fig. Ib, c). Although the time-course var-
ies slightly between the various types of glycosamino-
glycans the maximum intensity of scattered light
was recorded between 14 and 18 h of complex for-
mation, independent of the type and the concentra-
tion of the glycosaminoglycan studied (fig. 1).
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Fig. 1. Time course of the complex formation between various
glycQsarninoglycans and N-cetylpyridinium Chloride moni-
tored by läser light scattering measurements. The con-
ditions were äs described in fig. 2
a) highly sulphated heparan sulphate (l25-mg/l),
b) glycosaminoglycan polysulphate (Arteparon) in con-
centrations (mg/1) of 125 (O O), 62.5 (x-. x),
31^25 (O O),
c) chohdroitin sulphate in concentrations (mg/1) of
125 (O O) 31.3 <x—x) and 7.8 (O—^O).
Significant differences in the concentration depend-
ency of laser light scattering were found between the
specific types of glycosaminoglycans (figs. 2, 3, 4).
Chondroitin sulphate develops a more inteiise light
scattering than dermatan sulphate whereas keratan
sulphate is unable to pfoduce light scattering in the
presence of N-cetylpyridiniuin vthloride (fig. 2).
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Fig. 2 Laser light scattering of thc N-cetylpyridinium Chloride-
glycosaminoglycan complex äs function of variable con-
ccntrations of chondroitin sulphate (O O), dermatan
sulphalc (x x) and keratan sulphate (O O).
Inereasing concentrations of glycosaminoglycans in
0.03 mol/1 NaCI were incubated for 24 h with N-cetylpy-
ridinium Chloride. Complex formation was recorded by








Fig. 3. Laser light scattering of the N-cetylpyridinium chloride-
glycosaminoglycan complex äs function of variable con-
centrations of hyaluroriic acid (1) and glycosaminoglycan
polysulphate (2, Arteparon).
The conditions were äs described in figure 2.
Thus, the latter type of glycosaminoglycan cannot be
measured by the laser nephelometric method. The
intensity of light scattering is independent of the
presence or absence of sulphate groups in the car-
bohydrate chain. This is documented in figure 3
which shows for hyahironic acid a much stronger
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Fig. 4. Laser light scattering of the N-cetylpyridinium chloride-
glycosaminoglycan complex äs function of variable con-
centrations of high-sulphated heparan sulphate ( ,
sulphate/hexosamine ratio 2.40), Iow-sulphated heparan
sulphate (A A, sulphate/hexosamine ratio 0.31). high
molecular weight hcparin (O O, sulphate/hexosamine
ratio 1.87), and low molccular weight heparin (O O,
sulphate/hexosamine ratio 1.86).
The conditions of the assay were äs described in figurc 2.
fig. 3) than for glycosaminoglycan polysulphate (2 in
fig. 3), a chemically over-sulphated chondroitin sul-
phate with a sulphate/hexosamine molar ratio of 4.0.
However, different degrees of sulphation of heparan
sulphate influence significantly the development of
laser light scattering in the presence of N-cetylpyrid-
inium Chloride (fig. 4). Similar concentrations of a
higher sulphated subfraction (sulphate/hexosamine
molar ratio 2.4) produces much more light scattering
than the lower sulphated fraction (sulphate/hexo-
samine molar ratio 0.31) (fig. 4). Two types of he-
parin, differing in the chain length but having identi-
cal sulphate/hexosamine molar ratios of l .87, gener-
ate similar light scattering curves (fig. 4). Thus, for
the property of scattering laser light the degree of
sulphation of a certain type of glycosaminoglycan
seems to be more important than certain variations
of the lengths of the carbohydrate chain.
Although the final concentration of N-cetylpyridini-
um Chloride in the assay, routinely 28 mmol/I, can be
varied over a wide ränge without affecting the inten-
sity of scattered light (täb. 1), care has to be taken
that the cpncentration of the ammonium salt is in
excess of that of the glycosaminoglycans. Otherwise
falsely low concentrations of glycosaminoglycans
may be recorded, due to reduced light scattering.
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Tab. 1. Effcct of variable concentralions of N-cetylpyridinium
Chloride on thc intensity of lasen light scattering produced
in thc presence of 22.5 mg/1 glycosaminoglycan polysul-
phate (Artcparon).
The reaction was performed in 0.03 mol/1 NaCl, the incu-
bation period was 24 h.
Concentration of














With respect to the ionic conditions, optimal light
scattering was produced in approximately 0.03 mol/1
NaCl. In 0.3 mol/1 NaCl the light scattering was not
reproducible due to a non-homogeneous Suspension
of the insoluble \glycosaminoglycan-N-cetylpyridini-
um chloride complexes (tab. 2).
Tab. 2. Effect of variable concentrations of NaCl on laser light
scattering in the presence of 22.5 mg/1 glycosaminoglycan
polysulphate and 0.028 mol/1 N-cetylpyridinium chlo-
ride. The mixture was incubated for 24 h.
Concentration of NaCl
(mol/1)










In table 3 the linear ranges and detection limits of
the laser nephelometric determinations of various,
purified glycosaminoglycans are listed. The detec-
tion limit is defined s the result which is clearly dif-
ferent from the matrix (a solution of 28 mmol/1 N-
cetylpyridinium chloride in 0.03 mol/1 NaCl), de-
fined s 3 Standard deviations of the appropriate
blank value (62). If based on a detection limit of the
carbazole reaction (60) of about 10 μιηοΐ/ΐ uronic
acid and an uronic acid content of chondroitin sul-
phate of 1.3 μπιοΐ/mg, the laser nephelometric de-
tection limit of l mg/1 chondroitin sulphate (tab. 3)
corresponds to an uronic acid Concentration of
1.3μιήο1/1. Thus, laser nephelometry proves to be
about 8 times more sensitive than quahtitation of
chondroitin sulphate by the carbazole method. Tak-
ing-into account a minimum filling volume of the las-
er nephelometry cuvette of 0.2 ml, laser nephelome-
try enables the precise determination of an amount
of glycosaminoglycan equivalent to 0.25 nmol uronic
acid. As already mentioned keratan sulphate is not
measurablb by to procedure.
Tab. 3. Detection limits and linear ranges of the laser nephelo-
metric determination of various glycosaminoglycans.
The glycosaminoglycans described in "Materials" were
dissolved in 0.03 mol/1 NaCl. The detection limit, defined
s the analytical result which is clearly detectable and dif-
ferent from the blank value (3 Standard deviations of the
blank value) was assessed by succe^sive dilutions of a
stock solution. Addition of N-cetylpyridinium chloride
and incubation were s described in "Methods".
Type of glycosaminoglycan Detection limit Linear r nge
(mg/1) (scattered (mg/1)
light, V)
Chondroitin sulphate l 0.7 1-100
Dermatan suiphate 5 0.4 5-125
Heparin (low molecular
weight) 8 0.7 8- 30
Heparin (high moleeular
weight) 5 <0.6 5^ 30
Heparan sulphate (highly
sulfated) 5 0.3 5- 90
Hyaluronic acid 3.5 0.5 3.5- 20
Keratan sulphate -=· — —
Results of precision control analyses of the determi-
nation of various concentrations f chondroitin sul-
phate by the laser nephelometric method re sum=
marized in table 4.
Tab. 4. Intra^assay and inter-assay precision of the laser nephelo^
metric measurement of chondroitin sulphate from bovine
tracheal cartilage. The glycosaminoglycan was used in 3
different concentrations (62.5 mg/1, 45.0 mg/l,
25.0 mg/1), the determination was performed s de-
scribed in "Methods".
Intra^assay precision inter-assay preeision
·· —— · »— -
Number of
determinations 20 20 20 10 10 10
Light scattering
mean(V) 14.73 9.90 5.47 14.38 10.06 4.93
S.D. (V) 0.66 0.34 0.25 1.03 0.55 0.48
Coefficient of
Variation (%) 4.4 3.4 4.5 7.1 5.4 9.7
Laser nephel metric lly recorded differentiation of
arteficial mixtures of glycosaminoglycans by succes-
sive degradation with nitrous acid, hyaluronate lyase,
and chondroitin lyase
An application of the laser nephelometric principle
to the determination f the composition of glyeosa-
minoglycans in a variety of biological fluids necessi-
tates the differentiation between the various types of
glycosaminoglycans. Therefore, a discriniin ting
method was developed whieh is basfed on the relative
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Tab. 5. Recovery of individual glycosaminoglycans in a synthetic mixture of 4 specific, highly purified glycosaminoglycans by chcmical
and cnzymatic treatment followed by lascr light scattering measurements.
A solution containg dermatan sjulphate (40 mg/I), chondroitining sulphate (10 mg/1), heparan sulphate (10 mg/1), and hyaluronic
acid (5 mg/1) in 0.03 mmol/1 NaCl wasprepared. The light scattering of eadh type of glycosaminoglycan at the respective concen-
traiion was determined separately to obtain the fraction of total light scattering due .to a specific type. Then, the mixture was
sequentially degraded with nitrous acid, hyaluronale lyase and chondroitin AC/ABC lyases to mcasure the scattered light due to
hcparan sulphate, hyaluronic acid, chondroitin sulphate, and dermatan sulphate, respectively, äs described in "Methods".
The type-specific scattered light measured is expressed äs fraction (recovery) of that determined for the respective glycosamino-







































reduction of light scattering obtained by degradation
of N-sulphated glycosaminoglycans, i.e. heparin and
heparan sulphate, with nitrous acid, by degradation
of hyaluronic acid with hyaluronate lyase, arid by
degradation of chondroitin sulphate and dermatan
sulphate with chondroitin AC and ABC lyases. Due
to the limited specificity of chondroitin lyases, which
also degrade to a certain extent hyaluronate, the di-
gestion of the latter type of glycosaminoglycan with
hyaluronate lyase should be performed before the
chondroitin lyases are used. Hyaluronate lyase
proves to be specific for hyaluronic acid (57). Apply-
ing this approach füll recovery of the individual types
in a complex synthetic mixture of 4 glycosaminogly-
cans is achieved (tab. 5), which indicates both the
specificity and sensitivity of the procedure. Howev-
er, care has to be taken with the control incubations
because they scatter laser light more intensely (about
2 to 4 V) than the non-treated, native samples.
The possible interference of polynucleotides with the
laser nephelometric assay was studied. Concentra-
tions of ribosomal RNA up to 13 mg/1 produce light
scattering lower than 0.1 V. A similar concentration
of high molecular weight DNA scatters laser light at
an intensity of 3.2 V in the presence of Nhcetylpyridi-
nium Chloride. Concentrations of DNA lower than
6 mg/1 were without significant effect on light scat-
tering (<0.1 V). Thus, physiologic Concentrations of
DNA and RNA in body fluids, which are far below
those tested here, are unlikely to affect the laser ne-
phelometric estimation of glycosaminoglycans.
Comparison of the laser nephelometric and turbidi-
metric measurement of specific types of glycos-
aminoglycans
In relation to nephelometry the turbidimetric assay
of glycosaminoglycans proves to be quite insensitive
(tab. 6). Irrespective of the type of glycosaminogly-
can studied, both the detection limits and the upper
limits of the linear ranges are much higher for turbi-
dimetry than for nephelometry. Typical, turbidimet-
rically determined calibration curves of various gly-
cosaminoglycans are shown in figure 5. The preci-
sion of the turbidimetric measurement of glycosa-
minoglycans (45 mg/1 chondroitin sulphate) is char-
acterized by intra-assay (n = 20) and inter-assay
(n = 10) coefficients of Variation of 6% and 10%,
respectively.
Tab. 6. Measurement of some glycosaminoglycans by laser ne-
phelometry and turbidimetry at 340 nm. Comparison of
detection limits (see tab. 3) and linear ranges. Analytic








































Laser nephelometric determination of the relative
concentration and composition of glycosaminogly-
cans in synovial fluids
Based on clinical-chemical, cytological and physico-
chemical criteria (56), synovial fluids (n = 38) were
subdivided into those of inflammatory and non-in-
flammatory origin and subjected to a laser nephelo-
metric determination of the relative concentration of
glycosaminoglycans (light scattering units/ml synov-
ial fluid). It was found that synovial fluids from non-
J. Clin. Chem. Clin. Biochem. / Vol. 21, 1983 / No. 7
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Fig. 5. Absorbance at 340 nm of the N-cetylpyridinium chlofide-
glycosaminoglycan complex äs function of variable con-
centrations of chondroitin sulphate ( ), dermatan
sulphate (x-* x) and highly sulphated heparan sulphate
( ).
The conditions of incubation were äs descrtibed in fig. 2,
and the absorbance at 340 nm was read using a centrifugal
fast analyzer.
inflammatory joint diseases contain about 4.5 times
more light scattering units/ml than those of inflam-
matory diseases. However, a considerable interindi-
vidual Variation was noted (tab. 7). A fraction of
more than 0.98 of the N-cetylpyridinium chloride-
induced light scattering in synovial fluid could be ab-
olished by treatment of the specimens with hyaluro-
nate lyase. Thus, in both pathological conditions,
light scattering is due to the nearly exclusive pres-
ence of hyaluronic acid.
Tab. 7. Relative concentration of hyaluronic acid in synovial
fluids from inflammatory and non-inflammatory joint dis-
eases. The differentiation is based on cytologic, clinical-
chemical and physicochemical criteria (56). 0.1 ml of syn-
ovial fluid was diluted l : 40 with 0.03 mol/1 NaCl, and
0.5 ml of the dilution was subjected to treatment with
hyaluronate lyase, filtered and incubated with N-cetylpy^
ridinium Chloride äs described in "Methods".
The fraction of light scattering due to the presence of
hyaluronic acid was more than 0.98 of total laser light
scattering. The mean values ± S.D. are listed.










As detailed in the present study the laser nephelo-
metrically recorded formation of complexes between
glycosaminoglycans and N-cetylpyridinium Chloride
can be utilized under certain conditions for a reliable
measurement of total and specific glycosaminogly-
cans. The method proves sensitive, precise, inexpen-
sive and irelatively simple, and is therefore probably
widely applicable. In coiftparison to the previously
described turbidimetric measurement of glycosamin-
oglycans using either N-cetylpyridinium Chloride
(48, 49) or cetyltrimethylammoniurn bromide (47)
äs complexing agents, the sensitivity of the nephelo^
metric method is superior$ this is also the case in- the
immunologic measurement of proteins with the two
procedures. Therefore, the laser nephelometric priii^
ciple niight also be advantageous for the determina-
tion of glycosaminoglycans in low concentrations in
tissue extracts (e.g. biopsy specimens), cell culture
exträcts, or in fluids available only in small amounts
(e.g. amniotic fluid). Laser nephelometry häs re-
cently proved to be useful in the estimation of glyco-
saminoglycans in human serum (51). Corripared with
the quantitation of glycosaminQglycans by determi-
nation of uronic acid, laser nephelometric measure-
ment is much more simple, has an even higher sensi-
tivity and is independent of the type of uronic acid
(which is known to influence the carbazole reaction
(60)).
The laser nephelometric method is based on the
measurement of glycosaminoglycans by virtue of
their polyanionic structure. Soine of the dfawbacks
of the proposed method are related to the complicat-
ed, physico-chemically carefully explored ifiterac-
tions of glycosaminoglycans with quaternäry ammo^
nium salts (42, 43, 63). The complex formation is
known to be dependent on the ioriic strerigth and the
pH of the solution (42). A precipitating complex
does not occur with keratan sulphate in the presence
of excess N-cetylpyridinium Chloride (42, 43, 64).
Thus, the lätter type of glycosaminoglycans is not
measurable with the nephelometric method (fig, 2).
Furthermore, small moleeular weight fractions of
glycosaminoglycans (< octasaccharides) do not form
complexes with the organic cations anc& hence, will
be not detectable. This fact seems to be noteworthy
since glycosaminoglycans in uf ine and serum, prqba=
bly in other body fluids äs well* are partly low mölec-
ular weight breakdown products of the;,high moleeu-
lar weight aggregates present in connective tissue
(41). The most serious complication of the method
arises from the dependency of the complex forma-
tion not only on the chain length- but also on the de-
gree of $ulphation or Charge detisity of the glycos-^
J. CJin. Chem. Clin. Biochem. / Vol. 21, 1983 / No. 7
Gressner et al.: Laser nephelometric detcrmination of glycosaminoglycans 415
aminoglycan; an example of this is presented in figure
4. The effect of the anionic structure of the glycos-
aminoglycan on the intensity of light scattering in the
presence of quaternary ammonium salts faises insu-
perable difficulties in the selection of appropriate
reference glycosaminoglycans (calibration curves)
necessary for the calculation of the concentrations of
glycosaminoglycans in biological materials. There-
fore it is more reliable to determine the relative frac-
tions of various glycosaminoglycans (tab. 7) rather
than absolute concentrations. Due to the arbitrary
choice of glycosaminoglycan Standards, the latter can
be only rough estimates. On the other hand, changes
of the relative amount and composition of glycosa-
minoglycans are detected with sensitivity by the ne-
phelometric method. The specificity of the N-cetyl-
pyridinium chloride-induced light scattering in syn-
ovial fluid for glycosaminoglycans is proved by its
complete abolition when glycosaminoglycans are de-
stroyed with hyaluronate lyase. In serum, there is a
high degrec of laser light scattering due to unspecific
reactions of N-cetylpyridinium Chloride with serum
components other than glycosaminoglycans (51). In
contrast, synovial fluids did not contain appreciable
concentrations of non-glycosaminoglycan molecules
that were able to form light scattering complexes
with the organiccations. Even high concentrations of
DNA and RNA do not interfere with the laser ne-
phelometry of glycosaminoglycans.
The specificity and efficiency of the chemical and en-
zymatic, laser nephelometrically monitored differen-
tiation of complex glycosaminoglycan mixtures is
substantiated by the complete recovery of the indi-
vidual compounds (tab. 5). The time required for the
development of optimal light scattering, between 14
and 18h, delays the performance of the assay in its
present form. However, light scattering can be read
reproducibly at 3 h if a reduction of sensitivity is ac-
cepted. Based on the concentration-dependent dif-
ferences in the time course of light scattering shown
in figure l we currently evaluate a peak rate modifi-
cation of the kinetic nephelometric assay instead of
the fixed-time method described here, in order to
prevent prolonged incubation times.
Using the laser nephelometric procedure we demon-
strate in synovial fluids of non-inflammatory joint
diseases a much higher light scattering due to hyalu-
ronic acid than in those of inflammatory origin. This
result accords with previous reports, which describe
significantly elevated concentrations of hyaluronate
in degenerative joint diseases in comparison to in-
flammatory articular lesions (e.g. rheumatoid arthri-
tis) (55, 56). Therefore, the laser nephelometric as-
say of synovial hyaluronic acid is suggested äs an ad-
ditional, simple and sensitive laboratory aid in the
discrimination between both pathogenetic types of
articular effusions.
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